# Request for Information: Next-Generation Imports Screening Decision Support Risk Targeting System

Canonical: https://abierto.us/opportunities/fdarfi75f40124q00178

- Solicitation number: FDA-RFI-75F40124Q00178
- Notice type: Sources sought
- Status: Closed. Deadline was March 28, 2024 at 12:00 PM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Office of Acq Grant SVCS (75F401)
- NAICS: 541512 Computer Systems Design Services
- Product or service code: 7A20 Application development software delivered by perpetual license, consisting of analysis, design, development, code, test and release packages associated with application development projects.
- Set-aside: Total small business set-aside
- Place of performance: Silver Spring, Maryland
- County: Montgomery County (FIPS 24031). https://abierto.us/counties/montgomery-county-md-24031
- City: Silver Spring. https://abierto.us/cities/silver-spring-md-2472450
- First posted: March 12, 2024
- Last posted: March 12, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/54a8b571713e4ada8510954125c18ae7/view

## Description

FDA’s Import Program is responsible for ensuring that all imported products comply with FDA regulations. If FDA determines through examination, sampling, or otherwise that a product is adulterated or misbranded, the product is subject to refusal of admission into the United States in accordance with Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act.

FDA receives large quantities of product and product-associated information, and, upon receipt in the form of import entries, a best course of action needs to be decided to protect public health. Legacy systems handling these data are generally siloed and limited, with the creation of interfaces or expansions being time-consuming.

Given advancing technologies, it is sought to transition to more flexible decision support systems for screening these entries that are capable of handling large amounts of data while supporting the general operational processes already in place.

## Publications

- March 12, 2024: Sources sought, due March 28, 2024 at 12:00 PM EDT. Notice 54a8b571713e4ada8510954125c18ae7. https://sam.gov/workspace/contract/opp/54a8b571713e4ada8510954125c18ae7/view

## Points of contact

- Noah Padilla, Noah.Padilla@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fdarfi75f40124q00178.